Literature DB >> 8435028

Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly.

T J Marrie1.   

Abstract

PURPOSE: To determine the frequency and the clinical characteristics of Mycoplasma pneumoniae pneumonia in the elderly.
METHODS: Analysis of cases of M pneumoniae pneumonia accumulated as part of a prospective study of community-acquired pneumonia.
RESULTS: Sixty-four (4.9%) of 1300 patients had pneumonia due to M pneumoniae. Six (9.3%) of the 64 were 65 years of age or older. None of the elderly patients had a discharge diagnosis of M pneumoniae compared with 21 of those 64 years of age or younger (36%). Sixty-four percent of the patients with M pneumoniae received erythromycin therapy compared with 45% of 1118 of the patients with community-acquired pneumonia. The clinical features of the six elderly patients with M pneumoniae did not allow distinction from other causes of pneumonia. One patient presented with normal pressure pulmonary edema due to infection with both M pneumoniae and respiratory syncytial virus; a second patient had his Salmonella carrier state converted to bacteremia during his episode of M pneumoniae. Three presented as nonspecific pneumonia in the elderly, while one patient had a slowly resolving infection due to a narrowed bronchus. The 58 patients who were 64 years of age or younger demonstrated four previously unrecognized or underemphasized features of M pneumoniae infection--prolonged thrombocytopenia, one patient; recurrent pulmonary hemorrhage, one patient; thrombocytosis, 45% of the patients; and prolonged hospital stay, eight (13.7%) of the 58 patients. Only one patient died (1.5%) and this was a result of Shy-Drager syndrome.
CONCLUSIONS: Mycoplasma pneumoniae accounts for 4.9% of community-acquired pneumonia requiring hospitalization, and 9% of these patients were 65 years of age or older. There are no clinical features that distinguish this form of pneumonia from that due to other agents. The mortality rate from this infection is low even in the elderly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435028

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Mycoplasma pneumoniae Pneumonia with Worsening Pleural Effusion Despite Treatment with Appropriate Antimicrobials: Case report.

Authors:  Kowthar S Hassan; Ghalib Al-Khadouri
Journal:  Sultan Qaboos Univ Med J       Date:  2018-09-09

3.  Clinical use of capillary PCR to diagnose Mycoplasma pneumonia.

Authors:  J Honda; T Yano; M Kusaba; J Yonemitsu; H Kitajima; M Masuoka; K Hamada; K Oizumi
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 4.  Community-acquired pneumonia in adults.

Authors:  D Y Sue
Journal:  West J Med       Date:  1994-10

Review 5.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 6.  Fulminant Mycoplasma pneumoniae pneumonia.

Authors:  E D Chan; C H Welsh
Journal:  West J Med       Date:  1995-02

7.  Clinical features of culture-proven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

Authors:  T A Madani; A A Al-Ghamdi
Journal:  BMC Infect Dis       Date:  2001-07-04       Impact factor: 3.090

8.  Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

Authors:  Heike von Baum; Tobias Welte; Reinhard Marre; Norbert Suttorp; Christian Lück; Santiago Ewig
Journal:  BMC Infect Dis       Date:  2009-05-13       Impact factor: 3.090

Review 9.  A Compendium for Mycoplasma pneumoniae.

Authors:  Gretchen L Parrott; Takeshi Kinjo; Jiro Fujita
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

Review 10.  Mycoplasma pneumoniae: A Potentially Severe Infection.

Authors:  Bharat Bajantri; Sindhaghatta Venkatram; Gilda Diaz-Fuentes
Journal:  J Clin Med Res       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.